Search at Vanderbilt-Ingram Cancer Center

1144 results found

Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Nave Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib

Relevance: 1

Evaluation of RBS2418 in Subjects With Advanced, Metastatic Solid Tumors

Relevance: 1

Neoadjuvant Darolutamide Alone or in Combination With Standard Therapy for Stage II-IIIA, AR+, TNBC

Relevance: 1

Expanded Access Protocol (EAP) for Nonconforming (NC) Afami-cel

Relevance: 1

Cemiplimab for the Treatment of Locally Advanced Head and Neck Basal Cell Carcinoma Before Surgery

Relevance: 1

Study of LY3537982 in Cancer Patients With a Specific Genetic Mutation (KRAS G12C)

Relevance: 1

A Study of a New Way to Treat Children and Young Adults With a Brain Tumor Called NGGCT

Relevance: 1

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

Relevance: 1

A Phase 1 Study of AB521 Monotherapy and Combination Therapies in Renal Cell Carcinoma and Other Solid Tumors

Relevance: 1

Testing the Use of Ado-Trastuzumab Emtansine Compared to the Usual Treatment (Chemotherapy With Docetaxel Plus Trastuzumab) or Trastuzumab Deruxtecan for Recurrent, Metastatic, or Unresectable HER2-Expressing Salivary Gland Cancers

Relevance: 1